Safety of Propranolol Therapy for Severe Infantile Hemangioma.

MLA

Prey, Sorilla, et al. “Safety of Propranolol Therapy for Severe Infantile Hemangioma.” JAMA: Journal of the American Medical Association, vol. 315, no. 4, Jan. 2016, pp. 413–15. EBSCOhost, https://doi.org/10.1001/jama.2015.13969.

APA

Prey, S., Voisard, J.-J., Delarue, A., Lebbe, G., Taïeb, A., Leaute-Labreze, C., & Ezzedine, K. (2016). Safety of Propranolol Therapy for Severe Infantile Hemangioma. JAMA: Journal of the American Medical Association, 315(4), 413–415. https://doi.org/10.1001/jama.2015.13969

Chicago

Prey, Sorilla, Jean-Jacques Voisard, Alain Delarue, Geneviève Lebbe, Alain Taïeb, Christine Leaute-Labreze, and Khaled Ezzedine. 2016. “Safety of Propranolol Therapy for Severe Infantile Hemangioma.” JAMA: Journal of the American Medical Association 315 (4): 413–15. doi:10.1001/jama.2015.13969.